Michael J. Eble

7.1k total citations
173 papers, 4.1k citations indexed

About

Michael J. Eble is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael J. Eble has authored 173 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Pulmonary and Respiratory Medicine, 69 papers in Radiation and 47 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael J. Eble's work include Advanced Radiotherapy Techniques (69 papers), Prostate Cancer Diagnosis and Treatment (66 papers) and Prostate Cancer Treatment and Research (49 papers). Michael J. Eble is often cited by papers focused on Advanced Radiotherapy Techniques (69 papers), Prostate Cancer Diagnosis and Treatment (66 papers) and Prostate Cancer Treatment and Research (49 papers). Michael J. Eble collaborates with scholars based in Germany, United States and Netherlands. Michael J. Eble's co-authors include Michael Pinkawa, Marc D. Piroth, Richard Holý, Bernd Gagel, Branka Asadpour, Jens Klotz, Karin Fischedick, Heinz H. Coenen, Gabriele Stoffels and Karl‐Josef Langen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Radiology.

In The Last Decade

Michael J. Eble

162 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. Eble Germany	36	2.4k	1.5k	1.5k	623	610	173	4.1k
Michael Pinkawa Germany	36	2.5k 1.1×	1.3k 0.9×	1.8k 1.2×	416 0.7×	494 0.8×	136	3.7k
Ute Ganswindt Germany	38	2.2k 0.9×	1.5k 1.0×	1.3k 0.9×	667 1.1×	813 1.3×	166	4.4k
Michelle DeSilvio United States	28	3.8k 1.6×	1.6k 1.1×	1.4k 0.9×	492 0.8×	132 0.2×	64	5.4k
Mark K. Buyyounouski United States	38	4.0k 1.7×	1.2k 0.8×	2.2k 1.5×	320 0.5×	90 0.1×	174	5.0k
Kazuhiko Ogawa Japan	39	2.0k 0.9×	900 0.6×	1.1k 0.7×	784 1.3×	506 0.8×	320	5.7k
Morand Piert United States	32	1.3k 0.6×	2.0k 1.3×	381 0.3×	786 1.3×	446 0.7×	79	3.6k
S. Supiot France	31	1.7k 0.7×	880 0.6×	840 0.6×	390 0.6×	115 0.2×	231	3.1k
Murray Wesson Australia	5	1.8k 0.8×	1.4k 1.0×	1.6k 1.1×	162 0.3×	302 0.5×	18	3.5k
Bernard Dubray France	30	1.6k 0.7×	1.4k 1.0×	1.1k 0.7×	300 0.5×	111 0.2×	119	3.1k
Stefanie Corradini Germany	31	1.7k 0.7×	1.4k 0.9×	1.8k 1.2×	790 1.3×	463 0.8×	207	3.6k

Countries citing papers authored by Michael J. Eble

Since Specialization

Citations

This map shows the geographic impact of Michael J. Eble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Eble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Eble more than expected).

Fields of papers citing papers by Michael J. Eble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Eble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Eble. The network helps show where Michael J. Eble may publish in the future.

Co-authorship network of co-authors of Michael J. Eble

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Eble. A scholar is included among the top collaborators of Michael J. Eble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Eble. Michael J. Eble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murad, M. Hassan, Marie‐Luise Berres, Alexander Koch, et al.. (2025). Potential radiotherapy-related reactivation of immune checkpoint inhibitor hepatitis. Strahlentherapie und Onkologie. 201(7). 752–758.

Popp, Ilinca, Wolfgang Weber, Erika Graf, et al.. (2024). Target Volume Delineation for the Re-Irradiation of Recurrent Glioblastoma: MRI- or PET-Based? Results of the GLIAA Prospective Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S119–S119.

Gonçalves, Miguel M., Mareike Tometten, Ashkan Rashad, et al.. (2023). Stereotactic radiotherapy in the management of oligometastatic and recurrent head and neck cancer: a single-center experience. Strahlentherapie und Onkologie. 200(5). 400–408. 3 indexed citations

Knüchel, Ruth, et al.. (2022). Effective Radiosensitization of Bladder Cancer Cells by Pharmacological Inhibition of DNA-PK and ATR. Biomedicines. 10(6). 1277–1277. 7 indexed citations

Pinkawa, Michael, et al.. (2020). Quality of life more than 10 years after radiotherapy for localized prostate cancer—impact of time after treatment and prescription dose. Quality of Life Research. 30(2). 437–443. 6 indexed citations

Kirschner‐Hermanns, Ruth, et al.. (2019). Quality of Life Changes >10 Years After Postoperative Radiation Therapy After Radical Prostatectomy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(2). 382–388. 5 indexed citations

Kirschner‐Hermanns, Ruth, et al.. (2018). Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer. Brachytherapy. 17(3). 517–523. 7 indexed citations

Mottaghy, Felix M., et al.. (2018). Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT. Strahlentherapie und Onkologie. 194(7). 638–645. 17 indexed citations

Eble, Michael J., et al.. (2018). Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy. Strahlentherapie und Onkologie. 195(5). 383–392. 5 indexed citations

10.

Pinkawa, Michael, et al.. (2017). Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year Results. International Journal of Radiation Oncology*Biology*Physics. 99(2). 374–377. 36 indexed citations

11.

Kirschner‐Hermanns, Ruth, et al.. (2017). Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer – focus on overall survival. Radiation Oncology. 12(1). 98–98. 15 indexed citations

12.

Pinkawa, Michael, et al.. (2016). Hydrogel injection reduces rectal toxicity after radiotherapy for localized prostate cancer. Strahlentherapie und Onkologie. 193(1). 22–28. 31 indexed citations

13.

Piroth, Marc D. & Michael J. Eble. (2014). Intraoperative Radiotherapy with electrons. Translational Cancer Research. 3(2). 167–174.

14.

Uhl, Matthias, et al.. (2013). Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: Results of a multi-institutional phase II trial. Radiotherapy and Oncology. 106(2). 215–219. 58 indexed citations

15.

Pinkawa, Michael, Marc D. Piroth, Richard Holý, et al.. (2009). Dose-escalation using intensity-modulated radiotherapy for prostate cancer – Evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost. Radiotherapy and Oncology. 93(2). 213–219. 61 indexed citations

16.

Pinkawa, Michael, Bernd Gagel, Marc D. Piroth, et al.. (2007). Postoperative Radiotherapy for Prostate Cancer. Strahlentherapie und Onkologie. 183(1). 23–29. 32 indexed citations

17.

Gagel, Bernd, Marc D. Piroth, Michael Pinkawa, et al.. (2006). Gemcitabine Concurrent with Thoracic Radiotherapy after Induction Chemotherapy with Gemcitabine/Vinorelbine in Locally Advanced Non-Small Cell Lung Cancer. Strahlentherapie und Onkologie. 182(5). 263–269. 17 indexed citations

18.

Zimny, Michael, Bernd Gagel, Kurt Hamacher, et al.. (2006). FDG—a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer. European Journal of Nuclear Medicine and Molecular Imaging. 33(12). 1426–1431. 95 indexed citations

19.

Wiegel, Thomas, Alessandra Siegmann, Julian Willner, et al.. (2004). A Multicenter Analysis of 123 Patients with Recurrent Rectal Cancer within the Pelvis. Frontiers of radiation therapy and oncology. 38. 41–51. 1 indexed citations

20.

Kallinowski, F., et al.. (1995). Intraoperative radiotherapy for primary and recurrent rectal cancer. European Journal of Surgical Oncology. 21(2). 191–194. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact